These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24636244)

  • 61. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early Biomarkers and Regulatory Innovation in Multidrug-Resistant Tuberculosis.
    Wallis RS; Peppard T
    Clin Infect Dis; 2015 Oct; 61Suppl 3():S160-3. PubMed ID: 26409278
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Development and study of structure-activity relationship of drugs against Mycobacterium tuberculosis].
    Baska F; Székely ER; Szántai-Kis C; Bánhegyi P; Hegymegi-Barakonyi B; Németh G; Breza N; Zsákai L; Greff Z; Pató J; Kéri G; Orfi L
    Acta Pharm Hung; 2013; 83(3):88-95. PubMed ID: 24369587
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 66. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

  • 67. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
    Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
    [TBL] [Abstract][Full Text] [Related]  

  • 68. From the Centers for Disease Control and Prevention. Performance evaluation program for Mycobacterium tuberculosis drug-susceptibility testing process.
    JAMA; 1994 Feb; 271(5):341. PubMed ID: 8283573
    [No Abstract]   [Full Text] [Related]  

  • 69. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
    Raja S; Prakash CR
    Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis.
    Palomino JC; Martin A
    Future Microbiol; 2016; 11(4):539-47. PubMed ID: 27070731
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug-resistant tuberculosis in chronic excretors in Casablanca, Morocco.
    El Baghdadi J; Laaboudi L; Bartal M; Benslimane A
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):267. PubMed ID: 10094331
    [No Abstract]   [Full Text] [Related]  

  • 72. A comparative study on the activities of six combination regimens against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice.
    Zheng M; Jin H; Fu L; Xu J; Wang B; Zhao W; Zhu H; Li P; Lu Y; Li Q
    J Chemother; 2013 Apr; 25(2):81-6. PubMed ID: 23684355
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dynamic time-kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis.
    Vaddady PK; Trivedi A; Rathi C; Madhura DB; Liu J; Lee RE; Meibohm B
    Eur J Pharm Sci; 2019 Jan; 127():233-239. PubMed ID: 30419293
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe.
    van der Werf MJ; Ködmön C; Catchpole M
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28572128
    [No Abstract]   [Full Text] [Related]  

  • 75. Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe.
    Heldal E; Van Deun A; Chiang CY; Rieder HL
    Eur Respir J; 2017 Jun; 49(6):. PubMed ID: 28572127
    [No Abstract]   [Full Text] [Related]  

  • 76. Steroid acid amides of diamino diphenyl sulfone.
    BERCZELLER A
    Dis Chest; 1958 May; 33(5):474-81. PubMed ID: 13524091
    [No Abstract]   [Full Text] [Related]  

  • 77. Membrane transport systems and the biodegradation potential and pathogenicity of genus Rhodococcus.
    de Carvalho CC; Costa SS; Fernandes P; Couto I; Viveiros M
    Front Physiol; 2014; 5():133. PubMed ID: 24772091
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Spectinamides: a challenge, a proof, and a suggestion.
    Viveiros M; Pieroni M
    Trends Microbiol; 2014 Apr; 22(4):170-1. PubMed ID: 24636244
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug-resistant tuberculosis: a new shot on goal.
    Nathan C
    Nat Med; 2014 Feb; 20(2):121-3. PubMed ID: 24504402
    [No Abstract]   [Full Text] [Related]  

  • 80. Antibacterial drugs: Redesigned antibiotic combats drug-resistant tuberculosis.
    Cully M
    Nat Rev Drug Discov; 2014 Apr; 13(4):256. PubMed ID: 24658308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.